These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23400686)

  • 1. Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.
    Dionysopoulos D; Pavlakis K; Kotoula V; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Nikolaou A; Kalogeras KT; Fountzilas G
    Strahlenther Onkol; 2013 Mar; 189(3):202-14. PubMed ID: 23400686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.
    Mountzios G; Kostopoulos I; Kotoula V; Sfakianaki I; Fountzilas E; Markou K; Karasmanis I; Leva S; Angouridakis N; Vlachtsis K; Nikolaou A; Konstantinidis I; Fountzilas G
    PLoS One; 2013; 8(1):e54048. PubMed ID: 23365645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
    Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.
    Bellacosa A; Almadori G; Cavallo S; Cadoni G; Galli J; Ferrandina G; Scambia G; Neri G
    Clin Cancer Res; 1996 Jan; 2(1):175-80. PubMed ID: 9816104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis.
    Chrysovergis A; Gorgoulis VG; Giotakis I; Tsiambas E; Karameris A; Kittas C; Kyroudi A
    Med Oncol; 2011 Sep; 28(3):871-7. PubMed ID: 20373052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
    Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    Ahmed RA; Shawky Ael-A; Hamed RH
    Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
    Chang AR; Wu HG; Park CI; Jun YK; Kim CW
    Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 protein tissue detection in laryngeal cancer.
    Segas JV; Lazaris AC; Nikolopoulos TP; Kavantzas NG; Lendari IE; Tzagkaroulakis AM; Patsouris ES; Ferekidis EA
    ORL J Otorhinolaryngol Relat Spec; 2005; 67(6):319-25. PubMed ID: 16327270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer.
    Lazaridis G; Lambaki S; Karayannopoulou G; Eleftheraki AG; Papaspirou I; Bobos M; Efstratiou I; Pentheroudakis G; Zamboglou N; Fountzilas G
    Strahlenther Onkol; 2014 Jul; 190(7):636-8, 640-5. PubMed ID: 24658605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
    Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
    J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
    Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
    Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
    Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
    Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.
    Pignataro L; Sambataro G; Pagani D; Pruneri G
    Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):75-85. PubMed ID: 16116829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
    Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
    Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.